BACK TO ALL STUDIES

Remnant Inpatient and Clinic Sample Surveillance study, UNC Labs (HRS-CoV)

PRIMARY OBJECTIVE(s)

To identify SARS-2 prevalence in a remnant sample-based cohort over a 12 month period.

PRINCIPAL INVESTIGATOR(S)

Alena Markmann

CONTACT
John Guiliano, Alena Markman
alena.markmann@unchealth.unc.edu
TREATMENT/CLINICAL & LAB INVESTIGATION

No treatment, SARS-2 ELISA antibody testing

POPULATION
Clinic and hospital visit/encounter based population
FULL NAME OF DIAGNOSTIC TEST
Lab Used for Diagnostic Test
Full Name of Serology/Antibody Test

DeSilva lab assay

Lab Used for Serology/Antibody Test
DeSilva lab at UNC
Want more information about this study?
study website